本文選題：地塞米松 + 支氣管哮喘�。� 參考：《山西醫(yī)科大學(xué)》2012年碩士論文

【摘要】：目的： 探討支氣管哮喘大鼠氣道重塑與其血清白介素-8（interleukin-8）、肺組織表皮生長因子（Epidermal Growth Factor,EGF）表達的關(guān)系及地塞米松早、晚期的干預(yù)效果。 方法： 40只清潔級wistar雄性大鼠，隨機分為4組：模型組（N組）、對照組（C組）、地塞米松早期干預(yù)組(E組)、地塞米松晚期干預(yù)組(L組)，每組各10只，用10%卵蛋白(Ovalbumin，，OVA)抗原混懸液腹腔注射致敏，1%卵清白蛋白霧化誘喘，以制備大鼠哮喘氣道重塑模型。其中地塞米松早、晚期干預(yù)組在不同時期給予地塞米松進行干預(yù)。而對照組大鼠用生理鹽水代替卵蛋白致敏和誘喘。ELISA法測血清中IL-8含量，肺組織切片HE染色，計算機圖像分析氣道形態(tài)學(xué)參數(shù)，衡量氣道重塑程度，免疫組化法測定肺組織中EGF含量。數(shù)據(jù)分析用SPSS17.0統(tǒng)計軟件處理。 結(jié)果： 除C組外，其余各組均有氣道重塑的病理改變；與C組大鼠相比較，各組大鼠氣道重塑程度較重、血清IL-8濃度升高、肺組織EGF表達上調(diào)(P0.05)；與N組大鼠相比較，各組大鼠均有氣道重塑程度較輕、血清IL-8濃度下降、肺組織EGF表達下調(diào)(P0.05)；與E組相比較，L組和N組大鼠氣道重塑程度較重、血清IL-8濃度升高、肺組織EGF表達上調(diào)(P0.05)；另外，各組大鼠血清IL-8濃度、肺組織EGF表達與氣道重塑程度相關(guān)(P0.001)。 結(jié)論： 在大鼠支氣管哮喘氣道重塑模型中證實地塞米松可以有效抑制氣道重塑，且早期應(yīng)用更能盡早阻斷其病程的進展；同時地塞米松可以下調(diào)IL-8、EGF的表達，而且IL-8、EGF含量與氣道重塑程度呈正相關(guān)，由此推測地塞米松可能是通過抑制IL-8、EGF表達的途徑來干預(yù)氣道重塑，另外IL-8、EGF也可能作為衡量氣道重塑程度重要指標(biāo)之一。
[Abstract]:Objective: To investigate the relationship between airway remodeling and the expression of interleukin-8 in serum and epidermal Growth factor-EGFin in lung tissue of asthmatic rats and the effect of dexamethasone on the early and late stage of dexamethasone. Methods: Forty clean grade wistar male rats were randomly divided into four groups: model group (n group), control group (group C), dexamethasone early intervention group (group E) and dexamethasone late intervention group (group L) with 10 rats in each group. The airway remodeling model of asthmatic rats was established by injecting 10% ovalbumin OVA antigen suspension intraperitoneally with 1% ovalbumin and 1% ovalbumin to induce asthma. Dexamethasone in early and late intervention group was given dexamethasone in different periods. In the control group, the rats were sensitized by normal saline instead of ovalbumin and panting. Elisa was used to measure the content of IL-8 in serum, HE staining in lung tissue sections, morphological parameters of airway in computer image analysis, and the degree of airway remodeling. The content of EGF in lung tissue was determined by immunohistochemical method. Data analysis is processed by SPSS17.0 statistical software. Results: There were pathological changes of airway remodeling in all groups except group C. compared with group C, the degree of airway remodeling was heavier, the concentration of serum IL-8 was higher, the expression of EGF in lung tissue was up-regulated (P0.05), and compared with group N, the degree of airway remodeling in each group was higher than that in group C. Compared with group E, the degree of airway remodeling in group L and group N was more severe, the concentration of serum IL-8 was higher, and the expression of EGF in lung tissue was up-regulated (P 0.05). The concentration of serum IL-8 and the expression of EGF in lung tissue were correlated with the degree of airway remodeling in each group (P 0.001). Conclusion: In rat bronchial asthma airway remodeling model, dexamethasone can effectively inhibit airway remodeling, and early application of dexamethasone can block the progression of airway remodeling, and dexamethasone can down-regulate the expression of IL-8 and EGF. Furthermore, the content of IL-8 EGF was positively correlated with the degree of airway remodeling, which suggested that dexamethasone might interfere with airway remodeling by inhibiting the expression of IL-8 EGF, and IL-8 EGF might also be one of the important indexes to measure the degree of airway remodeling.
【學(xué)位授予單位】：山西醫(yī)科大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2012
【分類號】：R562.25

【共引文獻】

相關(guān)期刊論文 前10條

1 楊程;彭波;童佳兵;王國俊;張四春;李澤庚;;肺氣虛證和肺陰虛證患者細胞因子變化的研究[J];中醫(yī)藥臨床雜志;2012年04期

2 趙世光;榮光生;仇煜;;支氣管舒張試驗的臨床應(yīng)用評價[J];安徽衛(wèi)生職業(yè)技術(shù)學(xué)院學(xué)報;2010年02期

3 許海棠;余啟梅;吳祖鳳;李秀;;支氣管舒張試驗對肺通氣功能正常的疑似哮喘患者應(yīng)用的意義[J];安徽醫(yī)學(xué);2009年11期

4 饒會林;陳慶;方浩徽;陳文化;陳根旺;王菁;李志禮;楊建安;闞曉宏;;安徽省部分經(jīng)濟欠發(fā)達農(nóng)村地區(qū)哮喘控制實施情況分析[J];安徽醫(yī)學(xué);2011年12期

5 張克昌;李維春;;支氣管哮喘患兒體內(nèi)嗜酸性粒細胞及IL-13TGF-β_1的檢測[J];安徽醫(yī)學(xué);2011年12期

6 李紹修,項秀雯,安維哨,陳紹奉;基層醫(yī)院咳嗽變異性哮喘常用診斷方法的比較[J];安徽醫(yī)藥;2004年02期

7 張秀梅;湯懿珍;;白三烯受體拮抗劑曲尼司特治療哮喘的效果觀察及護理[J];安徽醫(yī)藥;2007年08期

8 金炬;;脈沖振蕩法結(jié)合舒張試驗在支氣管哮喘與慢性阻塞性肺疾病鑒別診斷中的應(yīng)用[J];安徽醫(yī)藥;2008年08期

9 楊玲;;信必可都保聯(lián)合孟魯司特治療咳嗽變異性哮喘患者的療效觀察[J];安徽醫(yī)藥;2010年11期

10 羊禮榮;曹桂紅;;阿奇霉素治療小兒支氣管哮喘療效觀察[J];安徽醫(yī)藥;2011年01期

相關(guān)會議論文 前10條

1 李平;許萍;劉曉靜;;哮喘患者肺功能指標(biāo)與轉(zhuǎn)化生長因子β_1關(guān)系的研究[A];江西省中西醫(yī)結(jié)合學(xué)會呼吸病專業(yè)委員會首次學(xué)術(shù)會議論文集[C];2009年

2 趙吉平;譚程;張昶;;從肺腸論治針刺對支氣管哮喘患者AQLQ的影響[A];2011中國針灸學(xué)會年會論文集（摘要）[C];2011年

3 鄭勁平;;肺功能檢查流調(diào)相關(guān)問題淺析[A];呼吸與危重癥醫(yī)學(xué)（2010-2011）[C];2011年

4 金小紅;李紹波;王昕昕;陳玲玲;李鳳仙;陳麗麗;;特異性免疫治療對哮喘大鼠轉(zhuǎn)化生長因子β-1和CD4+CD25+調(diào)節(jié)性T細胞的影響[A];2011年浙江省醫(yī)學(xué)會兒科學(xué)分會學(xué)術(shù)年會暨兒內(nèi)科疾病診治新進展國家級學(xué)習(xí)班論文匯編[C];2011年

5 王真;楊s

本文編號：1789173